Which statement about the safety and efficacy of medications in children is accurate?
Children cannot give consent, so clinical drug trials are not performed on children.
Children can only be subjects in quasi-experimental clinical studies.
Data from adult clinical drug trials can be extrapolated to children.
Federal law requires that drugs for children be tested on children.
The Correct Answer is D
a) Children can participate in clinical drug trials when appropriate consent is obtained from parents or guardians and when the study complies with ethical guidelines. They are not excluded from trials entirely because they cannot give consent.
b) Children can participate in various types of clinical studies, not just quasi-experimental ones, as long as the study follows ethical and legal guidelines for pediatric research.
c) Data from adult clinical trials cannot always be directly applied to children due to physiological differences. Pediatric drug testing is necessary to ensure drugs are both safe and effective for children.
d) Federal law mandates that drugs for children undergo testing in pediatric populations. This is to ensure that drugs are safe and effective for children, as they may respond differently than adults to medications.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
a) Complete blood counts (CBC) are useful for monitoring infection, anemia, or bone marrow suppression, but they are not the primary concern for azithromycin and acetaminophen toxicity.
b) Electrolytes are important for general health but are not directly related to the major side effects of these drugs.
c) Liver enzymes (AST, ALT) should be monitored because both azithromycin and acetaminophen can cause hepatotoxicity, especially at high doses. Acetaminophen overdose is a known cause of liver failure.
d) Urinalysis may be helpful in assessing kidney function, but it is not the primary focus when monitoring for drug-induced liver toxicity.
Correct Answer is D
Explanation
a) Phase I studies focus on assessing the safety, dosing, and side effects of a drug in healthy volunteers, not its clinical effectiveness or potential new uses.
b) Phase II studies evaluate the drug's effectiveness and safety in a small group of patients with the targeted condition but do not focus on potential new uses.
c) Phase III studies are large-scale trials conducted to confirm the drug's effectiveness and safety before approval but do not typically involve studying new uses of the drug.
d) Phase IV studies occur after a drug has been approved and marketed. These studies, often called post-marketing surveillance, evaluate the drug's effectiveness and safety in the general population and investigate new potential uses or long-term effects.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.